Rational design, synthesis, and serine protease inhibitory activity of a novel P1-argininal derivative featuring a conformationally constrained P2–P3 bicyclic lactam moiety
摘要:
Based on molecular modeling and judicious combination of the salient topographic features of the recently discovered P-3-lactam derivative 1 with the P-2-prolyl derivatives 2a,b, the novel thrombin inhibitor 3a was designed. Inhibitor 3a incorporates a fused bicyclic lactam as a novel type of P-2-P-3 dipeptide surrogate. The synthesis and biological activity of this potent serine protease inhibitor is presented. (C) 1997, Elsevier Science Ltd.